$55.18
Currently 35 wall-street analysts regularly analyze the financials of Biomarin Pharmaceutical Inc. on a frequent basis to provide recommendations along with target share price. 35 analysts offering 12-month price forecasts for Biomarin Pharmaceutical Inc. (BMRN) have a share price target of $95.91. This median of share price forecast represents a 73.81% upside from the latest price of $55.18 as on 01.07.25.
As per the chart shown above, analysts believe that the Biomarin Pharmaceutical Inc. (BMRN) share price will touch around $95.91 in next 12-months.
Below is a chart showing the percentage difference between Biomarin Pharmaceutical Inc.'s share price and its median forecast price. As on 01.07.25, the difference is -34.62%
Based on 35 analysts tracking and researching Biomarin Pharmaceutical Inc. (BMRN) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 15 | 15 | 16 |
Outperform | 10 | 10 | 10 |
Hold | 10 | 9 | 9 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |